Methoxylated 2'-hydroxychalcones as antiparasitic hit compounds
- Eur J Med Chem. 2017 Jan 27:126:1129-1135. doi: 10.1016/j.ejmech.2016.12.017.
- 1. University of Modena and Reggio Emilia, Via Campi 103, 41125, Modena, Italy.
- 2. Institute for Molecular and Cell Biology, 4150-180 Porto, Portugal and Instituto de Investigação e Inovação em Saúde, Universidade do Porto and Institute for Molecular and Cell Biology, 4150-180, Porto, Portugal.
- 3. Complutense University of Madrid, 28040, Madrid, Spain.
- 4. Complutense University of Madrid, 28040, Madrid, Spain; Instituto de Investigación Hospital 12 de Octubre, Madrid, Spain.
- 5. Fraunhofer Institute for Molecular Biology and Applied Ecology Screening Port, Hamburg, Germany.
- 6. Fraunhofer Institute for Molecular Biology and Applied Ecology Screening Port, Hamburg, Germany. Electronic address: [email protected].
- 7. Fraunhofer Institute for Molecular Biology and Applied Ecology Screening Port, Hamburg, Germany. Electronic address: [email protected].
- 8. Brazilian Centre for Research in Energy and Materials, Campinas, Brazil.
- 9. Bernhard Nocht Institute for Tropical Medicine, D-20359, Hamburg, Germany.
- 10. University of Modena and Reggio Emilia, Via Campi 103, 41125, Modena, Italy. Electronic address: [email protected].
Chalcones display a broad spectrum of pharmacological activities. Herein, a series of 2'-hydroxy methoxylated Chalcones was synthesized and evaluated towards Trypanosoma brucei, Trypanosoma cruzi and Leishmania infantum. Among the synthesized library, compounds 1, 3, 4, 7 and 8 were the most potent and selective anti-T. brucei compounds (EC50 = 1.3-4.2 μM, selectivity index >10-fold). Compound 4 showed the best early-tox and antiparasitic profile. The pharmacokinetic studies of compound 4 in BALB/c mice using hydroxypropil-β-cyclodextrins formulation showed a 7.5 times increase in oral bioavailability.